Trial Outcomes & Findings for ROBODOC® Clinical Trials: Long-Term Follow-Up (NCT NCT01831219)

NCT ID: NCT01831219

Last Updated: 2017-01-11

Results Overview

Presence of osteolysis determined by looking at patient x-rays as described by Gruen et al and Johnson et al.

Recruitment status

COMPLETED

Target enrollment

118 participants

Primary outcome timeframe

14 months

Results posted on

2017-01-11

Participant Flow

Participant milestones

Participant milestones
Measure
ROBODOC
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Overall Study
STARTED
73
45
Overall Study
COMPLETED
40
21
Overall Study
NOT COMPLETED
33
24

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

ROBODOC® Clinical Trials: Long-Term Follow-Up

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ROBODOC
n=73 Participants
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=45 Participants
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Total
n=118 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
>=65 years
73 Participants
n=99 Participants
45 Participants
n=107 Participants
118 Participants
n=206 Participants
Age, Continuous
74.2 years
STANDARD_DEVIATION 8.2 • n=99 Participants
72.8 years
STANDARD_DEVIATION 7.6 • n=107 Participants
73.5 years
STANDARD_DEVIATION 7.7 • n=206 Participants
Gender
Female
NA Participants
n=99 Participants
NA Participants
n=107 Participants
NA Participants
n=206 Participants
Gender
Male
NA Participants
n=99 Participants
NA Participants
n=107 Participants
NA Participants
n=206 Participants
Region of Enrollment
United States
73 participants
n=99 Participants
45 participants
n=107 Participants
118 participants
n=206 Participants

PRIMARY outcome

Timeframe: 14 months

Presence of osteolysis determined by looking at patient x-rays as described by Gruen et al and Johnson et al.

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Presence of Osteolysis
2 Hips
2 Hips

PRIMARY outcome

Timeframe: 2 months

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) will be used to measure clinical outcome. The WOMAC total score ranges 96 (best) to 0 (worst). The WOMAC pain score ranges 0-20, the stiffness score ranges 0-8, and functional limitation score ranges 0-68.

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Western Ontario and McMaster Universities Osteoarthritis Index
8.44 units on a scale
Standard Deviation 11.48
11.32 units on a scale
Standard Deviation 11.92

SECONDARY outcome

Timeframe: 2 months

The Harris Hip Score will be measured to determine clinical outcome. The Harris Hip total score ranges 100 (best) to 0 (worst) and it is computed by the sum of the pain score (0-44 points), function (, 0-47 points), absence of deformity (4 points), and range of motion (5 points).

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Harris Hip Score
93.49 units on a scale
Standard Deviation 8.77
89.5 units on a scale
Standard Deviation 12.03

SECONDARY outcome

Timeframe: 2 months

The Health Status Questionnaire-12 (HSQ-12) will be used to measure clinical outcome. HSQ-12 total score ranges from 0 (worst) to 800 (best).

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Health Status Questionnaire-12
683.52 units on a scale
Standard Deviation 113.09
637.16 units on a scale
Standard Deviation 104.53

SECONDARY outcome

Timeframe: 2 months

The UCLA Activity Score will be used to measure clinical outcome. The UCLA Activity Score ranges 10 (best) to 0 (worst).

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
UCLA Activity Score
6.09 units on a scale
Standard Deviation 8.44
5.71 units on a scale
Standard Deviation 1.45

SECONDARY outcome

Timeframe: 2 months

The Visual Analog Scale pain questionnaire will be used to measure clinical outcome. The pain VAS is a continuous scale which range from 0 (no pain) to 100 \[100-mm scale\] ("worst imaginable pain" ).

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Visual Analog Pain Score
4.69 units on a scale
Standard Deviation 10.15
6.42 units on a scale
Standard Deviation 10.89

OTHER_PRE_SPECIFIED outcome

Timeframe: At follow-up visit (7-20 years post-operatively)

Implant survivorship will be determined from the medical history CRF by comparing the percentage of ROBODOC and manual control subjects who have required revision or re-operation THA procedures on the hip in question since their original study procedure which took place 7-20 years previously.

Outcome measures

Outcome measures
Measure
ROBODOC
n=45 Hips
The ROBODOC group received total hip arthroplasty using the ROBODOC Surgical system for preparation of the femoral canal for a femoral stem implant.
Conventional
n=22 Hips
The conventional group received total hip arthroplasty using the conventional manual tools including a broach to prepare the femoral cavity for femoral stem replacement.
Number of Operated Hips That Required Revision/Reoperation
1 Hips
1 Hips

Adverse Events

ROBODOC

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Conventional

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Senior Manager of Clinical Applications

Think Surgical

Phone: 510-249-2339

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place